CN111004179B - 一种5’-甲氧基劳丹素的拆分方法 - Google Patents
一种5’-甲氧基劳丹素的拆分方法 Download PDFInfo
- Publication number
- CN111004179B CN111004179B CN201911096976.2A CN201911096976A CN111004179B CN 111004179 B CN111004179 B CN 111004179B CN 201911096976 A CN201911096976 A CN 201911096976A CN 111004179 B CN111004179 B CN 111004179B
- Authority
- CN
- China
- Prior art keywords
- methoxy
- lapatin
- crude product
- solvent
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 92
- 239000012043 crude product Substances 0.000 claims abstract description 30
- 239000002904 solvent Substances 0.000 claims abstract description 25
- 229930195027 lapatin Natural products 0.000 claims abstract description 24
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims abstract description 15
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims abstract description 14
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical group COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000001953 recrystallisation Methods 0.000 claims abstract description 13
- 239000012046 mixed solvent Substances 0.000 claims abstract description 12
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 8
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 230000008569 process Effects 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims description 48
- 238000001914 filtration Methods 0.000 claims description 27
- 238000010438 heat treatment Methods 0.000 claims description 25
- 238000001816 cooling Methods 0.000 claims description 19
- 239000000706 filtrate Substances 0.000 claims description 16
- YONLFQNRGZXBBF-KBPBESRZSA-N (2s,3s)-2,3-dibenzoyloxybutanedioic acid Chemical compound O([C@H](C(=O)O)[C@H](OC(=O)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=CC=C1 YONLFQNRGZXBBF-KBPBESRZSA-N 0.000 claims description 14
- YONLFQNRGZXBBF-ZIAGYGMSSA-N (2r,3r)-2,3-dibenzoyloxybutanedioic acid Chemical group O([C@@H](C(=O)O)[C@@H](OC(=O)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=CC=C1 YONLFQNRGZXBBF-ZIAGYGMSSA-N 0.000 claims description 12
- NTBIYBAYFBNTCD-UHFFFAOYSA-N dibenzoyl 2,3-dihydroxybutanedioate Chemical compound C=1C=CC=CC=1C(=O)OC(=O)C(O)C(O)C(=O)OC(=O)C1=CC=CC=C1 NTBIYBAYFBNTCD-UHFFFAOYSA-N 0.000 claims description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 abstract description 28
- 235000019270 ammonium chloride Nutrition 0.000 abstract description 14
- 230000003287 optical effect Effects 0.000 abstract description 14
- 239000000126 substance Substances 0.000 abstract description 13
- 239000000047 product Substances 0.000 abstract description 9
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 230000006872 improvement Effects 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 42
- 238000001035 drying Methods 0.000 description 18
- 238000004128 high performance liquid chromatography Methods 0.000 description 18
- 239000012074 organic phase Substances 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 239000007788 liquid Substances 0.000 description 16
- 239000007787 solid Substances 0.000 description 16
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 238000010992 reflux Methods 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 238000004296 chiral HPLC Methods 0.000 description 13
- 239000012071 phase Substances 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 238000007865 diluting Methods 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 239000012065 filter cake Substances 0.000 description 7
- 229910000029 sodium carbonate Inorganic materials 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 230000001376 precipitating effect Effects 0.000 description 6
- 238000010828 elution Methods 0.000 description 4
- 238000000643 oven drying Methods 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 description 2
- 229910000387 ammonium dihydrogen phosphate Inorganic materials 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- VABUHUZDQFBOBL-UHFFFAOYSA-N ethanol;n-ethylethanamine Chemical compound CCO.CCNCC VABUHUZDQFBOBL-UHFFFAOYSA-N 0.000 description 2
- 235000019837 monoammonium phosphate Nutrition 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000012088 reference solution Substances 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- MMQNZPHFAPHRDA-UHFFFAOYSA-N 6,7-dimethoxy-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydroisoquinoline Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN=C1CC1=CC(OC)=C(OC)C(OC)=C1 MMQNZPHFAPHRDA-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 244000075898 Lantana strigocamara Species 0.000 description 1
- 238000007126 N-alkylation reaction Methods 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- KGPAYJZAMGEDIQ-UHFFFAOYSA-N laudanosine Natural products C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1C KGPAYJZAMGEDIQ-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- -1 xylyl carbamate Chemical compound 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
时间(min) | 流动相A% | 流动相B% |
0 | 100 | 0 |
25 | 60 | 40 |
50 | 0 | 100 |
55 | 0 | 100 |
56 | 100 | 0 |
65 | 100 | 0 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911096976.2A CN111004179B (zh) | 2019-11-11 | 2019-11-11 | 一种5’-甲氧基劳丹素的拆分方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911096976.2A CN111004179B (zh) | 2019-11-11 | 2019-11-11 | 一种5’-甲氧基劳丹素的拆分方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111004179A CN111004179A (zh) | 2020-04-14 |
CN111004179B true CN111004179B (zh) | 2021-03-09 |
Family
ID=70111960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911096976.2A Active CN111004179B (zh) | 2019-11-11 | 2019-11-11 | 一种5’-甲氧基劳丹素的拆分方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111004179B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111471013B (zh) * | 2020-05-26 | 2021-04-30 | 朗天药业(湖北)有限公司 | 一种米库氯铵及其注射液的制备方法 |
CN115073373A (zh) * | 2022-07-08 | 2022-09-20 | 广东嘉博制药有限公司 | 一种不对称合成(r)-5’-甲氧基劳丹素的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8418303D0 (en) * | 1984-07-18 | 1984-08-22 | Wellcome Found | Compounds |
CN103880744A (zh) * | 2012-12-21 | 2014-06-25 | 常州工程职业技术学院 | 一种5’-甲氧基劳丹素的制备方法 |
CN107778234B (zh) * | 2016-08-26 | 2023-01-06 | 四川科瑞德制药股份有限公司 | 一种神经肌肉阻滞剂中间体的制备方法 |
CN108926564A (zh) * | 2017-05-26 | 2018-12-04 | 四川科瑞德制药股份有限公司 | 一种非去极化肌松剂组合物及其制备方法和用途 |
-
2019
- 2019-11-11 CN CN201911096976.2A patent/CN111004179B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN111004179A (zh) | 2020-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111004179B (zh) | 一种5’-甲氧基劳丹素的拆分方法 | |
US8357805B2 (en) | (1R,1′R)-atracurium salts separation process | |
CN112876454A (zh) | 一种人工合成(r,s)-尼古丁盐的制备方法 | |
CN111100067A (zh) | 一种新的扑尔敏杂质及其制备工艺 | |
CN111440152B (zh) | 一种伏立康唑的制备方法 | |
CN110240586A (zh) | 2,3-二氢-1H-苯并[f]色满-2-胺衍生物的制备方法 | |
CN114249711A (zh) | 一种拆分制备尼古丁的方法 | |
CN100393694C (zh) | 四苄基伏格列波糖的结晶及制备方法 | |
CN106632312B (zh) | 一种阿哌沙班有关物质、中间体、制备方法及其应用 | |
CN106588903A (zh) | 利伐沙班中间体杂质、其制备方法以及分离纯化方法 | |
KR0144345B1 (ko) | 아미카신의 제조방법 | |
CN110734393B (zh) | N-苄基-3-氧代哌啶-4-羧酸乙酯盐酸盐的制备方法 | |
CN104876812B (zh) | 制备盐酸舍曲林中间体及杂质的方法 | |
CN107879966B (zh) | 一种西他沙星关键中间体的制备方法 | |
CN106946959B (zh) | 合成5,6,4'-三羟基黄酮-7-0-d-葡萄糖醛酸有关物质及其制备方法和应用 | |
CN105924409B (zh) | 一种(r)-1-((2-氯苯基)-(苯基)-甲基)-哌嗪的拆分方法 | |
CN110818676A (zh) | 一种环己烷衍生物的晶型 | |
CN108689926A (zh) | 匹伐他汀钙5-氧代杂质的制备方法 | |
CN112824409B (zh) | 一种新杂质及其制备方法 | |
CN112409338B (zh) | 一种盐酸咪达唑仑糖浆杂质c和杂质d及其用途 | |
CN110894198A (zh) | 一种黄嘌呤类化合物及其制备方法和用途 | |
CN117924141A (zh) | 一种富马酸伏诺拉生关键杂质a和b的制备方法 | |
CN112898234A (zh) | 一种盐酸兰地洛尔中间体的制备方法 | |
US20170233334A1 (en) | Method for preparing d-arginine | |
CN112142804B (zh) | 一种地西他滨的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 430000 Jinyin Lake Ecological Park, Dongxihu District, Wuhan City, Hubei Province Patentee after: Yuanda Life Science (Wuhan) Co.,Ltd. Address before: 430040 Jinyin Lake Ecological Park, Dongxihu District, Wuhan City, Hubei Province Patentee before: WUHAN DOCAN PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 430000 No.1 Xiaoxiang West Road, Dongxihu District, Wuhan City, Hubei Province Patentee after: Yuanda Medical Nutrition Science (Wuhan) Co.,Ltd. Country or region after: China Address before: 430000 Jinyin Lake Ecological Park, Dongxihu District, Wuhan City, Hubei Province Patentee before: Yuanda Life Science (Wuhan) Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |